Seshadri Neervannan, Ph.D. has served as our Chief Operating Officer since
July 2020. Dr. Neervannan reviously served as Senior Vice President of Global Pharmaceutical Development, from March 2015 to July 2020 at Allergan, and Vice President, Pharmaceutical Development, from January 2007 to February 2015 at Allergan
Inc., a global pharmaceutical company. Prior to Allergan he was Director of Pharmaceutics R&D, at Amgen Inc., a biotechnology company, from February 1999 to January 2007. From November 1994 to February 1999, Dr. Neervannan was Sr. Research
Investigator at Bristol-Myers Squibb Pharmaceutical Research Institute. Dr. Neervannan received a B.S. in Pharmacy (with Honors) from Birla Institute of Technology & Science, Pilani, India, and a Ph.D. (with Honors) in Pharmaceutical
Chemistry from the University of Kansas, Lawrence, KS.
Aziz Mottiwala has served as our Chief Commercial Officer since
August 2020. Mr. Mottiwala has served on the board of directors of OneOC, a non-profit organization based in Orange County, California since March 2018. Mr. Mottiwala previously served as Chief
Commercial Officer of Opiant Pharmaceutical, Inc., or Opiant, a publicly-traded pharmaceutical company specializing in medicines for the treatment of addictions and drug overdose from September 2019 to August 2020. Prior to Opiant,
Mr. Mottiwala served as Senior Vice President of Sales and Marketing and Head of Commercial at Avanir Pharmaceuticals, Inc., or Avanir, a pharmaceutical company specializing in medicines to treat nervous system disorders from July 2017 to
September 2019. Prior to Avanir, Mr. Mottiwala spent over ten years at Allergan, a global pharmaceutical company, in various roles from December 2006 to July 2017, most recently as Vice President of Marketing for Allergans eye car
portfolio from January 2014 to July 2017. Mr. Mottiwala holds a Bachelor of Science degree in Biochemistry from the University of California San Diego and an MBA in Marketing and Finance from the Marshall School of Business at the University of
Southern California.
Bryan Wahl, M.D., J.D. has served as our General Counsel since January 2021. Prior to this,
Dr. Wahl was a partner at Knobbe Martens Olson & Bear LLP from September 2005 through December 2020. Since 2009, Dr. Wahl has served as a Hospitalist with Kaiser Permanente and as a Hospitalist at several Bay Area medical centers
from September 2002 to December 2017. Dr. Wahl earned his Bachelors degree the University of Hawaii at Manoa, his Doctor of Medicine from the University of Hawaii John A. Burns School of Medicine and his Juris Doctorate from University of
California, Berkeley School of Law.
Dianne Whitfield has served as our Chief Human Resources Officer since January 2021.
Prior to this Ms. Whitfield served at Evolus as Vice President, Human Resources from January 2020 until January 2021 and as Executive Director, Human Resources from April 2019 until January 2020. From 2007 until April 2019, Ms. Whitfield
served as various roles at Allergan, including as Senior Manager, Human Resources (from October 2007 to March 2015), Senior Manager, Global Talent (from March 2015 to March 2016), Director, Global Talent (from March 2016 to October 2017) and
Director, Global Human Resources (from October 2017 to April 2019). Ms. Whitfield earned her Bachelors of Arts degree in Psychology and Social Behavior from the University of California, Irvine and a Masters degree in Social Work
from California State University, Long Beach.
Mark Holdbrook has served as our Vice President of Clinical Affairs since
November 2018. Prior to this Mr. Holdbrook was an independent consultant from October 2017 to November 2018 and served as Senior/Executive Director for Oculeve, which was acquired by Allergan, from May 2014 to October 2017. Mr. Holdbrook
received a B.A. from the University of California at San Diego.
Non-Employee Directors
Michael Ackermann, Ph.D. has served as a member of our Board of Directors and as chairperson of our Board of Directors since July
2017. Dr. Ackermann has been the Chief Executive Officer of Presidio Medical, Inc. since September 2017. From October 2017 until October 2020, Mr. Ackermann served as the chairman of the board of Oyster Point Pharma. Prior to that, he was
Vice President, Neurostimulation for Allergan from August 2015 to June 2017 after serving as Chief Executive Officer of Oculeve, which was acquired by Allergan, from June 2012 to August 2015. Dr. Ackermann received a B.E. in biomedical
engineering
7